
    
      Study Design: Intervention Model: Single Group Assignment Masking: Open Label

      Primary Outcome Measures:

      Recurrence-free survival in neoadjuvant intravesical mitomycin-C 40mg/20ml instillation group
      and control group.

      Secondary Outcome Measures:

      Progression-free survival in neoadjuvant intravesical mitomycin-C 40mg/20ml instillation
      group and control group.

      Time to recurrence in neoadjuvant intravesical mitomycin-C 40mg/20ml instillation group and
      control group.

      Change of tumor size after neoadjuvant intravesical mitomycin-C 40mg/20ml instillation.

      Safety of neoadjuvant intravesical mitomycin-C 40mg/20ml instillation.
    
  